Search Menu

PREMIER Symposium Report

On March 16, 2018 the international symposium on ‘Quality Management for Academic Research in Preclinical Biomedicine: Burden or Boon?’ took place. The symposium served as a forum to discuss the challenges of quality management in a research environment that thrives on curiosity and creativity. This event …

Read more

New PAASP publication: ‘The reproducibility crisis in preclinical research – lessons to learn from clinical research’

In this article, Laia Pedro-Roig and Christoph Emmerich discuss ways and measures how preclinical research and development (especially in its confirmatory phase) would benefit from adapting some of the internationally accepted quality standards and principles used in clinical research. In contrast to clinical research, with generally …

Read more

PAASP is part of the BMBF-funded GOT-IT (‘Guidelines On Target Validation for Innovative Therapeutics’) Project

Medical progress and continued supply of innovative medicines can only be guaranteed by continuous research and development of new active drugs and therapeutics. The most important starting point for the identification of new drugs are disease-modifying targets. Thus, the proper validation of pharmaceutically relevant targets based …

Read more

New PAASP member

We are delighted to announce that Malgorzata Pietraszek has joined our PAASP Team. Malgorzata has over 20 years of experience in CNS pharmacology acquired in both pharmaceutical industry and academic environments. Malgorzata holds a PhD from the Institute of Pharmacology Polish Academy of Sciences (PAS) in …

Read more

Scroll Up